Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

Association of genetic variants with atrial fibrillation.

Yamase Y, Kato K, Horibe H, Ueyama C, Fujimaki T, Oguri M, Arai M, Watanabe S, Murohara T, Yamada Y.

Biomed Rep. 2016 Feb;4(2):178-182. Epub 2015 Dec 2.

2.

SUMOylation Confers Posttranslational Stability on NPM-ALK Oncogenic Protein.

Vishwamitra D, Curry CV, Shi P, Alkan S, Amin HM.

Neoplasia. 2015 Sep;17(9):742-754. doi: 10.1016/j.neo.2015.09.005.

3.

Skp1 in lung cancer: clinical significance and therapeutic efficacy of its small molecule inhibitors.

Liu YQ, Wang XL, Cheng X, Lu YZ, Wang GZ, Li XC, Zhang J, Wen ZS, Huang ZL, Gao QL, Yang LN, Cheng YX, Tao SC, Liu J, Zhou GB.

Oncotarget. 2015 Oct 27;6(33):34953-67. doi: 10.18632/oncotarget.5547.

4.

ALK and crizotinib: after the honeymoon…what else? Resistance mechanisms and new therapies to overcome it.

Rolfo C, Passiglia F, Castiglia M, Raez LE, Germonpre P, Gil-Bazo I, Zwaenepoel K, De Wilde A, Bronte G, Russo A, Van Meerbeeck JP, Van Schil P, Pauwels P.

Transl Lung Cancer Res. 2014 Aug;3(4):250-61. doi: 10.3978/j.issn.2218-6751.2014.03.01. Review.

5.

Oncogene mimicry as a mechanism of primary resistance to BRAF inhibitors.

Sos ML, Levin RS, Gordan JD, Oses-Prieto JA, Webber JT, Salt M, Hann B, Burlingame AL, McCormick F, Bandyopadhyay S, Shokat KM.

Cell Rep. 2014 Aug 21;8(4):1037-48. doi: 10.1016/j.celrep.2014.07.010. Epub 2014 Aug 7.

6.

Extracellular signal-regulated kinase 2 (ERK2) mediates phosphorylation and inactivation of nuclear interaction partner of anaplastic lymphoma kinase (NIPA) at G2/M.

Illert AL, Zech M, Moll C, Albers C, Kreutmair S, Peschel C, Bassermann F, Duyster J.

J Biol Chem. 2012 Nov 2;287(45):37997-8005. doi: 10.1074/jbc.M112.373464. Epub 2012 Sep 6.

7.

Targeted inactivation of nuclear interaction partner of ALK disrupts meiotic prophase.

Illert AL, Kawaguchi H, Antinozzi C, Bassermann F, Quintanilla-Martinez L, von Klitzing C, Hiwatari M, Peschel C, de Rooij DG, Morris SW, Barchi M, Duyster J.

Development. 2012 Jul;139(14):2523-34. doi: 10.1242/dev.073072. Epub 2012 Jun 13.

8.

APC/C(Cdh1)-mediated degradation of the F-box protein NIPA is regulated by its association with Skp1.

Klitzing Cv, Huss R, Illert AL, Fröschl A, Wötzel S, Peschel C, Bassermann F, Duyster J.

PLoS One. 2011;6(12):e28998. doi: 10.1371/journal.pone.0028998. Epub 2011 Dec 20.

9.

The potential for crizotinib in non-small cell lung cancer: a perspective review.

Bang YJ.

Ther Adv Med Oncol. 2011 Nov;3(6):279-91. doi: 10.1177/1758834011419002.

10.

Secreted Mycobacterium tuberculosis Rv3654c and Rv3655c proteins participate in the suppression of macrophage apoptosis.

Danelishvili L, Yamazaki Y, Selker J, Bermudez LE.

PLoS One. 2010 May 4;5(5):e10474. doi: 10.1371/journal.pone.0010474.

12.

Anaplastic lymphoma kinase: signalling in development and disease.

Palmer RH, Vernersson E, Grabbe C, Hallberg B.

Biochem J. 2009 May 27;420(3):345-61. doi: 10.1042/BJ20090387. Review.

13.

NPM/ALK binds and phosphorylates the RNA/DNA-binding protein PSF in anaplastic large-cell lymphoma.

Galietta A, Gunby RH, Redaelli S, Stano P, Carniti C, Bachi A, Tucker PW, Tartari CJ, Huang CJ, Colombo E, Pulford K, Puttini M, Piazza RG, Ruchatz H, Villa A, Donella-Deana A, Marin O, Perrotti D, Gambacorti-Passerini C.

Blood. 2007 Oct 1;110(7):2600-9. Epub 2007 May 30.

14.

Pathobiology of ALK+ anaplastic large-cell lymphoma.

Amin HM, Lai R.

Blood. 2007 Oct 1;110(7):2259-67. Epub 2007 May 22. Review.

15.

Evaluation of enrichment techniques for mass spectrometry: identification of tyrosine phosphoproteins in cancer cells.

Schumacher JA, Crockett DK, Elenitoba-Johnson KS, Lim MS.

J Mol Diagn. 2007 Apr;9(2):169-77.

Supplemental Content

Support Center